Cargando…

Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds

Obesity and type 2 diabetes are emerging global epidemics associated with chronic, low-grade inflammation. A characteristic feature of type 2 diabetes is delayed wound healing, which increases the risk of recurrent infections, tissue necrosis, and limb amputation. In health, inflammation is actively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yunan, Zhang, Michael J., Hellmann, Jason, Kosuri, Madhavi, Bhatnagar, Aruni, Spite, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554373/ https://www.ncbi.nlm.nih.gov/pubmed/23043160 http://dx.doi.org/10.2337/db12-0684

Ejemplares similares

An Essential Role of NRF2 in Diabetic Wound Healing
por: Long, Min, et al.
Publicado: (2016)

Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats
por: Tong, Miao, et al.
Publicado: (2012)

Topical Fluoxetine as a Novel Therapeutic That Improves Wound Healing in Diabetic Mice
por: Nguyen, Chuong Minh, et al.
Publicado: (2019)

Restoration of Proresolution Pathway with Exogenous Resolvin D1 Prevents Sevoflurane-Induced Cognitive Decline by Attenuating Neuroinflammation in the Hippocampus in Rats with Type 2 Diabetes Mellitus
por: Sun, Qingmei, et al.
Publicado: (2021)

CCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity
por: Hellmann, Jason, et al.
Publicado: (2016)

Nrf2 Suppression Delays Diabetic Wound Healing Through Sustained Oxidative Stress and Inflammation
por: Li, Min, et al.
Publicado: (2019)

Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
por: Cummings, Bethany P., et al.
Publicado: (2010)

The Effects of Proresolution of Ellagic Acid in an Experimental Model of Allergic Airway Inflammation
por: de Freitas Alves, Claudiney, et al.
Publicado: (2013)

Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy
por: Schuhmacher, Swenja, et al.
Publicado: (2011)

Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey
por: Gallo, Marco, et al.
Publicado: (2015)

Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice
por: Meloni, Marco, et al.
Publicado: (2012)

Non-invasive monitoring of pharmacodynamics during the skin wound healing process using multimodal optical microscopy
por: Rico-Jimenez, Jose, et al.
Publicado: (2020)

Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
por: Singleton, Matthew J., et al.
Publicado: (2020)

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2016)

In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis
por: Benabdoun, Houda Abir, et al.
Publicado: (2019)

Neutralization of excessive CCL28 improves wound healing in diabetic mice
por: Chen, Zhenlong, et al.
Publicado: (2023)

Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2014)

Metformin Treatment in the Period After Stroke Prevents Nitrative Stress and Restores Angiogenic Signaling in the Brain in Diabetes
por: Abdelsaid, Mohammed, et al.
Publicado: (2015)

Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
por: Duan, Franklin F., et al.
Publicado: (2015)

Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland
por: Ruokoniemi, Päivi, et al.
Publicado: (2014)

Ephrin-B2–Activated Peripheral Blood Mononuclear Cells From Diabetic Patients Restore Diabetes-Induced Impairment of Postischemic Neovascularization
por: Broquères-You, Dong, et al.
Publicado: (2012)

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
por: Ekström, Nils, et al.
Publicado: (2015)

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2021)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
por: Cangemi, Roberto, et al.
Publicado: (2012)

Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory
por: Geng, Kang, et al.
Publicado: (2021)

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
por: Chow, Elaine, et al.
Publicado: (2023)

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2011)

Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
por: Zheng, Hongting, et al.
Publicado: (2011)

MG53 Does Not Manifest the Development of Diabetes in db/db Mice
por: Wang, Qiang, et al.
Publicado: (2020)

Chemical Composition and Anti-Candidiasis Mediated Wound Healing Property of Cymbopogon nardus Essential Oil on Chronic Diabetic Wounds
por: Kandimalla, Raghuram, et al.
Publicado: (2016)

Adiponectin Pretreatment Counteracts the Detrimental Effect of a Diabetic Environment on Endothelial Progenitors
por: Leicht, Simon F., et al.
Publicado: (2011)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial
por: Kerckhove, Nicolas, et al.
Publicado: (2016)

Antiaging Gene Klotho Attenuates Pancreatic β-Cell Apoptosis in Type 1 Diabetes
por: Lin, Yi, et al.
Publicado: (2015)

MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice
por: Liu, Xian Shuang, et al.
Publicado: (2017)

Aliskiren Attenuates the Inflammatory Response and Wound Healing Process in Diabetic Mice With Periodontal Disease
por: Oliveira, Sandra Helena Penha, et al.
Publicado: (2019)

Amphibian-derived wound healing peptides: chemical molecular treasure trove for skin wound treatment
por: Yin, Saige, et al.
Publicado: (2023)

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus
por: Gross, Jorge Luiz, et al.
Publicado: (2013)

Antidiabetic Effects of Pterosin A, a Small-Molecular-Weight Natural Product, on Diabetic Mouse Models
por: Hsu, Feng-Lin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k7dgu9afkge5291glo918pnv26